Owner Merck Patent GmbH

Inventors Gillies, Stephen D

Agent Davies Collison Cave

Pub. Number AU-B-2002357784

PCT Number PCT/US02/38780

PCT Pub. Number WO2003/048334

Priority 60/371,966 12.04.02 US; 60/337,113 04.12.01 US

Filing date 4 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 31 July 2008

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent